Investigation of the factors affecting the sexual function in women of reproductive age referred to the Women's Clinic of Hakim Neyshabur Hospital in 2015, Iran
The aim of this study was to determine the factors affecting the sexual function of women of reproductive age with reference to the adverse effects of sexual dysfunction in women and its consequences on family life. This research was a cross-sectional study conducted in 2014-2015 and the study population included married women with stable sexual activities (at least for the last four weeks) referred to Women’s Clinics of Hakim Neyshabur Hospital, Iran. The criteria for this study were as follows: being at the fertility age, being married and having regular sexual activity during the last four weeks. The study also included the women with a history of vaginal surgery, uterine surgery, vaginal or uterine anomalies, mental illness, any use of psychoactive or narcotic drugs. A standard questionnaire for women's sexual function (FSFI) was used for data collection. Data were analyzed using SPSS16 software, chi-square test, and one-way analysis of variance. The findings showed that the prevalence of sexual dysfunction was significantly related to the level of education, husband's employment status, family income, specific diseases, and husband's education (p < 0.05). Moreover, the highest prevalence was found for orgasmic disorder, lubrication disorder, libido disorder, sti-mulation disorder, and sexual dysfunction. Sexual abnormalities are highly prevalent in women of reproductive age, and the establishment of counseling and educational centers to identify these women and their needs seem to be necessary.
Segraves RT. Emerging therapies for female sexual dysfunction. Expert Opinion on Emerging Drugs. 2003;8(2):515–22.
2.
Oksuz E, Malhan S. Prevalence and Risk Factors for Female Sexual Dysfunction in Turkish Women. Journal of Urology. 2006;175(2):654–8.
3.
Hisasue S ichi, Kumamoto Y, Sato Y, Masumori N, Horita H, Kato R, et al. Prevalence of female sexual dysfunction symptoms and its relationship to quality of life: A Japanese female cohort study. Urology. 2005;65(1):143–8.
4.
Bakouie F, Omidvar S, F AN. Determining the frequency of sexual dysfunction in married women and some related factors in Babol city. J MUBABOL. 2008;9:59–64.
5.
Sungur MZ, Gündüz A. A Comparison of DSM-IV-TR and DSM-5 Definitions for Sexual Dysfunctions: Critiques and Challenges. The Journal of Sexual Medicine. 2014;11(2):364–73.
6.
Lewis RW, Fugl-Meyer KS, Corona G, Hayes RD, Laumann EO, Moreira ED, et al. ORIGINAL ARTICLES: Definitions/Epidemiology/Risk Factors for Sexual Dysfunction. The Journal of Sexual Medicine. 2010;7(4_Part_2):1598–607.
7.
Ponholzer A, Roehlich M, Racz U, Temml C, Madersbacher S. Female Sexual Dysfunction in a Healthy Austrian Cohort: Prevalence and Risk Factors. European Urology. 2005;47(3):366–75.
8.
Sidi H, Puteh SEW, Abdullah N, Midin M. The Prevalence of Sexual Dysfunction and Potential Risk Factors That May Impair Sexual Function in Malaysian Women. The Journal of Sexual Medicine. 2007;4(2):311–21.
9.
Heiman JR. Sexual dysfunction: Overview of prevalence, etiological factors, and treatments. Journal of Sex Research. 2002;39(1):73–8.
10.
Goldstein I. Female sexual arousal disorder: new insights. International Journal of Impotence Research. 2000;12(S4):S152–7.
11.
sh K. About the impotence of man.Tehran. Danesh Publishing. 2016;18.
12.
Herdt G. On the Development of Sexual Attraction. Archives of Sexual Behavior. 2000;29(6):527–9.
13.
Motta-Mena NV, Puts DA. Endocrinology of human female sexuality, mating, and reproductive behavior. Hormones and Behavior. 2017;91:19–35.
14.
Jones E. The Early Development of Female Sexuality. Female Sexuality. 2018. p. 133–45.
15.
Nappi RE, Cucinella L. Advances in pharmacotherapy for treating female sexual dysfunction. Expert Opinion on Pharmacotherapy. 2015;16(6):875–87.
16.
McCabe MP, Sharlip ID, Lewis R, Atalla E, Balon R, Fisher AD, et al. Incidence and Prevalence of Sexual Dysfunction in Women and Men: A Consensus Statement from the Fourth International Consultation on Sexual Medicine 2015. The Journal of Sexual Medicine. 2016;13(2):144–52.
17.
Nappi RE, Cucinella L. Advances in pharmacotherapy for treating female sexual dysfunction. Expert Opinion on Pharmacotherapy. 2015;16(6):875–87.
18.
Vital M, de Visme S, Hanf M, Philippe HJ, Winer N, Wylomanski S. Using the Female Sexual Function Index (FSFI) to evaluate sexual function in women with genital mutilation undergoing surgical reconstruction: a pilot prospective study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2016;202:71–4.
19.
Lee JT, Hu YL, Meston CM. The Sexual Satisfaction Scale for Women (SSS-W): adaptation and validation of a traditional Chinese version in Taiwan. J Sex Marital Ther. 2018;29:1–34.
20.
Smith RL, Gallicchio L, Flaws JA. Factors Affecting Sexual Activity in Midlife Women: Results from the Midlife Health Study. Journal of Women’s Health. 2017;26(2):103–8.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
